---
title: Aurigene Pharmaceutical Services Limited vs GeNext Genomics Pvt. Ltd.
slug_a: aurigeneservices
slug_b: genextgenomics
site: cro
review_signal_gate: closed
canonical_path: /compare/aurigeneservices/genextgenomics
---

# Aurigene Pharmaceutical Services Limited vs GeNext Genomics Pvt. Ltd.

Side-by-side profile data from each company listing on this directory.

## Aurigene Pharmaceutical Services Limited

- Profile: [/companies/aurigeneservices](/companies/aurigeneservices)

Aurigene Pharmaceutical Services Limited — Integrated CRO-CDMO with 25+ years of discovery and development expertise across small and large molecules, operating 16 US FDA-inspected cGMP facilities across three manufacturing countries.

Services: 6. Modalities: 3. Indications: 0. Locations: 3. Certifications: 1. The strongest documented coverage currently appears in services (6).

### Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- Protein Engineering

### Modalities

- Small Molecule
- Biologics (Other)
- Peptide

### Indications

- Data not yet provided.

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)
- Functional Service Provider (FSP)

## GeNext Genomics Pvt. Ltd.

- Profile: [/companies/genextgenomics](/companies/genextgenomics)

GeNext Genomics Pvt. Ltd. — GeNext Genomics is a central India-based contract research organization offering recombinant protein, antibody, and assay development services. The company also sells research reagents and diagnostic kits.

Services: 8. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Discovery Research
- Protein Engineering
- Immunology & Inflammation Services
- Proteomics Services
- Bioinformatics & Data Science
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)

### Indications

- Data not yet provided.

### Phases

- Discovery

### Sourcing models

- Data not yet provided.